Sponsor:
Aegerion Pharmaceuticals, Inc.
Code:
NCT02325674
Conditions
Generalised Lipodystrophy
Partial Lipodystrophy
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Metreleptin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations